| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 4,300 | $35.98 | $154.71kSell |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.93 | $553.95Sell |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.81 | $552.15Sell |
| Bradley Sitko | Chief Investment Officer | 2025-06-30 | 2,000 | $25.39 | $50.78kBuy |
| Owen Hughes | Chief Executive Officer | 2025-05-20 | 25,637 | $25.38 | $650.67kSell |
| Thomas M. Burns | SVP Finance CFO | 2025-05-20 | 10,482 | $25.38 | $266.03kSell |
| Bvf Partners L P | 10% Owner | 2025-05-16 | 265,316 | $27.10 | $7.19MSell |
| Bvf Partners L P | 10% Owner | 2025-05-16 | 127,407 | $27.10 | $3.45MSell |
| Bradley Sitko | Chief Investment Officer | 2025-04-07 | 2,000 | $24.70 | $49.40kBuy |
| Joseph M. Limber | Director | 2025-04-07 | 5,243 | $25.60 | $134.22kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Brothers Life Sciences Capital GP LLC | 112.56% | 13,606,093 | $478.53M | Insider |
| Baker Brothers Life Sciences LP | 112.56% | 13,606,093 | $478.53M | Insider |
| Bvf Inc | 21.43% | 2,590,303 | $91.10M | Institution |
| 667 LP | 13.12% | 1,585,591 | $55.77M | Insider |
| Baker Biotech Capital GP LLC | 13.12% | 1,585,591 | $55.77M | Insider |
| Morgan Stanley | 12.78% | 1,544,967 | $54.34M | Institution |
| Bvf Partners L P | 10.49% | 1,267,545 | $44.58M | Insider |
| Bvf GP Holdings LLC | 9.13% | 1,103,314 | $38.80M | Insider |
| Fmr LLC | 8.93% | 1,079,588 | $37.97M | Institution |
| Vanguard Group Inc | 5.28% | 638,813 | $22.47M | Institution |